Evidence map›Paper›PMID 35518711›Full record

ArticleToxicon: X2022

Preclinical efficacy testing of three antivenoms against

Mitchel Otieno Okumu, James Mucunu Mbaria, Joseph Kangangi Gikunju, Paul Gichohi Mbuthia, Vincent Odongo Madadi, Francis Okumu Ochola, Kenneth Narotso Maloba, Joseph Gichuki Nderitu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxicon: X, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mitchel Otieno OkumuDepartment of Public Health, Pharmacology, and Toxicology, University of Nairobi, Kenya.
James Mucunu MbariaDepartment of Public Health, Pharmacology, and Toxicology, University of Nairobi, Kenya.
Joseph Kangangi GikunjuDepartment of Medical Laboratory Science, Jomo Kenyatta University of Agriculture and Technology, Kenya.
Paul Gichohi MbuthiaDepartment of Veterinary Pathology, Microbiology, and Parasitology, University of Nairobi, Kenya.
Vincent Odongo MadadiDepartment of Chemistry, University of Nairobi, Kenya.
Francis Okumu OcholaDepartment of Pharmacology and Toxicology, Moi University, Kenya.
Kenneth Narotso MalobaDepartment of Public Health, Pharmacology, and Toxicology, University of Nairobi, Kenya.
Joseph Gichuki NderituDepartment of Public Health, Pharmacology, and Toxicology, University of Nairobi, Kenya.
University of Nairobi · KEJomo Kenyatta University of Agriculture and Technology · KEMoi University · KE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to determine the efficacy of Inoserp, Vins bioproducts, and South African Institute of Medical Research (SAIMR) polyvalent antivenoms in neutralizing

Indexed as

AntivenomsNaja asheiNeutralizationPotencySnakebite

Identifiers

PMID35518711
PMCPMC9065424
OpenAlexW4225015087

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.